nodes	percent_of_prediction	percent_of_DWPC	metapath
Midodrine—SLC15A1—Lisinopril—systemic scleroderma	0.396	0.52	CbGbCtD
Midodrine—SLC15A1—Captopril—systemic scleroderma	0.296	0.39	CbGbCtD
Midodrine—CYP2D6—Captopril—systemic scleroderma	0.0685	0.0901	CbGbCtD
Midodrine—Chills—Leflunomide—systemic scleroderma	0.000816	0.0034	CcSEcCtD
Midodrine—Cardiac disorder—Mycophenolic acid—systemic scleroderma	0.000805	0.00336	CcSEcCtD
Midodrine—Paraesthesia—Mometasone—systemic scleroderma	0.000802	0.00334	CcSEcCtD
Midodrine—Dysuria—Mycophenolate mofetil—systemic scleroderma	0.0008	0.00334	CcSEcCtD
Midodrine—Dry mouth—Captopril—systemic scleroderma	0.0008	0.00334	CcSEcCtD
Midodrine—Mental disorder—Leflunomide—systemic scleroderma	0.000797	0.00332	CcSEcCtD
Midodrine—Dyspnoea—Mometasone—systemic scleroderma	0.000796	0.00332	CcSEcCtD
Midodrine—Bradycardia—Lisinopril—systemic scleroderma	0.000796	0.00332	CcSEcCtD
Midodrine—Confusional state—Captopril—systemic scleroderma	0.000791	0.0033	CcSEcCtD
Midodrine—Pollakiuria—Mycophenolate mofetil—systemic scleroderma	0.000791	0.0033	CcSEcCtD
Midodrine—Angiopathy—Mycophenolic acid—systemic scleroderma	0.000787	0.00328	CcSEcCtD
Midodrine—Dyspepsia—Mometasone—systemic scleroderma	0.000786	0.00328	CcSEcCtD
Midodrine—Flatulence—Leflunomide—systemic scleroderma	0.00078	0.00325	CcSEcCtD
Midodrine—Chills—Mycophenolic acid—systemic scleroderma	0.000779	0.00325	CcSEcCtD
Midodrine—Urinary tract disorder—Lisinopril—systemic scleroderma	0.000772	0.00322	CcSEcCtD
Midodrine—Urethral disorder—Lisinopril—systemic scleroderma	0.000766	0.00319	CcSEcCtD
Midodrine—Back pain—Leflunomide—systemic scleroderma	0.000766	0.00319	CcSEcCtD
Midodrine—Tachycardia—Captopril—systemic scleroderma	0.000765	0.00319	CcSEcCtD
Midodrine—Pain—Mometasone—systemic scleroderma	0.000764	0.00318	CcSEcCtD
Midodrine—Muscle spasms—Leflunomide—systemic scleroderma	0.000761	0.00317	CcSEcCtD
Midodrine—Mental disorder—Mycophenolic acid—systemic scleroderma	0.00076	0.00317	CcSEcCtD
Midodrine—Flatulence—Mycophenolic acid—systemic scleroderma	0.000744	0.0031	CcSEcCtD
Midodrine—Stomatitis—Mycophenolate mofetil—systemic scleroderma	0.000744	0.0031	CcSEcCtD
Midodrine—Asthenia—Pentoxifylline—systemic scleroderma	0.000742	0.0031	CcSEcCtD
Midodrine—Tension—Mycophenolic acid—systemic scleroderma	0.000741	0.00309	CcSEcCtD
Midodrine—Erythema multiforme—Lisinopril—systemic scleroderma	0.000739	0.00308	CcSEcCtD
Midodrine—Nervousness—Mycophenolic acid—systemic scleroderma	0.000734	0.00306	CcSEcCtD
Midodrine—Pruritus—Pentoxifylline—systemic scleroderma	0.000732	0.00305	CcSEcCtD
Midodrine—Back pain—Mycophenolic acid—systemic scleroderma	0.000731	0.00305	CcSEcCtD
Midodrine—Gastrointestinal pain—Mometasone—systemic scleroderma	0.00073	0.00304	CcSEcCtD
Midodrine—Muscle spasms—Mycophenolic acid—systemic scleroderma	0.000726	0.00303	CcSEcCtD
Midodrine—Flushing—Lisinopril—systemic scleroderma	0.000726	0.00302	CcSEcCtD
Midodrine—Hepatobiliary disease—Mycophenolate mofetil—systemic scleroderma	0.000722	0.00301	CcSEcCtD
Midodrine—Insomnia—Captopril—systemic scleroderma	0.000709	0.00296	CcSEcCtD
Midodrine—Angiopathy—Lisinopril—systemic scleroderma	0.000709	0.00296	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—systemic scleroderma	0.000709	0.00296	CcSEcCtD
Midodrine—Abdominal pain—Mometasone—systemic scleroderma	0.000706	0.00294	CcSEcCtD
Midodrine—Paraesthesia—Captopril—systemic scleroderma	0.000704	0.00294	CcSEcCtD
Midodrine—Chills—Lisinopril—systemic scleroderma	0.000701	0.00292	CcSEcCtD
Midodrine—Dyspnoea—Captopril—systemic scleroderma	0.000699	0.00292	CcSEcCtD
Midodrine—Bradycardia—Mycophenolate mofetil—systemic scleroderma	0.000697	0.00291	CcSEcCtD
Midodrine—Somnolence—Captopril—systemic scleroderma	0.000697	0.00291	CcSEcCtD
Midodrine—Agitation—Mycophenolic acid—systemic scleroderma	0.000694	0.00289	CcSEcCtD
Midodrine—Dyspepsia—Captopril—systemic scleroderma	0.00069	0.00288	CcSEcCtD
Midodrine—Mental disorder—Lisinopril—systemic scleroderma	0.000685	0.00286	CcSEcCtD
Midodrine—Dizziness—Pentoxifylline—systemic scleroderma	0.000684	0.00285	CcSEcCtD
Midodrine—Hypertension—Leflunomide—systemic scleroderma	0.000684	0.00285	CcSEcCtD
Midodrine—Urinary tract disorder—Mycophenolate mofetil—systemic scleroderma	0.000676	0.00282	CcSEcCtD
Midodrine—Anxiety—Leflunomide—systemic scleroderma	0.000672	0.0028	CcSEcCtD
Midodrine—Urethral disorder—Mycophenolate mofetil—systemic scleroderma	0.000671	0.0028	CcSEcCtD
Midodrine—Flatulence—Lisinopril—systemic scleroderma	0.000671	0.0028	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic scleroderma	0.00067	0.00279	CcSEcCtD
Midodrine—Tension—Lisinopril—systemic scleroderma	0.000668	0.00278	CcSEcCtD
Midodrine—Skin disorder—Azathioprine—systemic scleroderma	0.000665	0.00277	CcSEcCtD
Midodrine—Nervousness—Lisinopril—systemic scleroderma	0.000661	0.00276	CcSEcCtD
Midodrine—Dry mouth—Leflunomide—systemic scleroderma	0.000659	0.00275	CcSEcCtD
Midodrine—Back pain—Lisinopril—systemic scleroderma	0.000658	0.00274	CcSEcCtD
Midodrine—Muscle spasms—Lisinopril—systemic scleroderma	0.000654	0.00273	CcSEcCtD
Midodrine—Rash—Pentoxifylline—systemic scleroderma	0.000652	0.00272	CcSEcCtD
Midodrine—Hypertension—Mycophenolic acid—systemic scleroderma	0.000652	0.00272	CcSEcCtD
Midodrine—Dermatitis—Pentoxifylline—systemic scleroderma	0.000652	0.00272	CcSEcCtD
Midodrine—Headache—Pentoxifylline—systemic scleroderma	0.000648	0.0027	CcSEcCtD
Midodrine—Feeling abnormal—Captopril—systemic scleroderma	0.000646	0.00269	CcSEcCtD
Midodrine—Gastrointestinal pain—Captopril—systemic scleroderma	0.000641	0.00267	CcSEcCtD
Midodrine—Anxiety—Mycophenolic acid—systemic scleroderma	0.000641	0.00267	CcSEcCtD
Midodrine—Asthenia—Mometasone—systemic scleroderma	0.000641	0.00267	CcSEcCtD
Midodrine—Irritability—Prednisone—systemic scleroderma	0.000641	0.00267	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	0.000639	0.00266	CcSEcCtD
Midodrine—Cardiac disorder—Mycophenolate mofetil—systemic scleroderma	0.000636	0.00265	CcSEcCtD
Midodrine—Nervous system disorder—Leflunomide—systemic scleroderma	0.000634	0.00264	CcSEcCtD
Midodrine—Pruritus—Mometasone—systemic scleroderma	0.000632	0.00263	CcSEcCtD
Midodrine—Tachycardia—Leflunomide—systemic scleroderma	0.000631	0.00263	CcSEcCtD
Midodrine—Dry mouth—Mycophenolic acid—systemic scleroderma	0.000629	0.00262	CcSEcCtD
Midodrine—Skin disorder—Leflunomide—systemic scleroderma	0.000628	0.00262	CcSEcCtD
Midodrine—Confusional state—Mycophenolic acid—systemic scleroderma	0.000622	0.00259	CcSEcCtD
Midodrine—Angiopathy—Mycophenolate mofetil—systemic scleroderma	0.000621	0.00259	CcSEcCtD
Midodrine—Abdominal pain—Captopril—systemic scleroderma	0.00062	0.00258	CcSEcCtD
Midodrine—Dry skin—Prednisone—systemic scleroderma	0.000615	0.00256	CcSEcCtD
Midodrine—Nausea—Pentoxifylline—systemic scleroderma	0.000615	0.00256	CcSEcCtD
Midodrine—Chills—Mycophenolate mofetil—systemic scleroderma	0.000615	0.00256	CcSEcCtD
Midodrine—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.000605	0.00252	CcSEcCtD
Midodrine—Tachycardia—Mycophenolic acid—systemic scleroderma	0.000602	0.00251	CcSEcCtD
Midodrine—Mental disorder—Mycophenolate mofetil—systemic scleroderma	0.0006	0.0025	CcSEcCtD
Midodrine—Skin disorder—Mycophenolic acid—systemic scleroderma	0.000599	0.0025	CcSEcCtD
Midodrine—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000591	0.00246	CcSEcCtD
Midodrine—Flatulence—Mycophenolate mofetil—systemic scleroderma	0.000588	0.00245	CcSEcCtD
Midodrine—Tension—Mycophenolate mofetil—systemic scleroderma	0.000585	0.00244	CcSEcCtD
Midodrine—Insomnia—Leflunomide—systemic scleroderma	0.000585	0.00244	CcSEcCtD
Midodrine—Paraesthesia—Leflunomide—systemic scleroderma	0.00058	0.00242	CcSEcCtD
Midodrine—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.000579	0.00241	CcSEcCtD
Midodrine—Anxiety—Lisinopril—systemic scleroderma	0.000577	0.00241	CcSEcCtD
Midodrine—Back pain—Mycophenolate mofetil—systemic scleroderma	0.000577	0.0024	CcSEcCtD
Midodrine—Dyspnoea—Leflunomide—systemic scleroderma	0.000576	0.0024	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.000575	0.0024	CcSEcCtD
Midodrine—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.000573	0.00239	CcSEcCtD
Midodrine—Dyspepsia—Leflunomide—systemic scleroderma	0.000569	0.00237	CcSEcCtD
Midodrine—Dry mouth—Lisinopril—systemic scleroderma	0.000567	0.00236	CcSEcCtD
Midodrine—Feeling abnormal—Azathioprine—systemic scleroderma	0.000564	0.00235	CcSEcCtD
Midodrine—Rash—Mometasone—systemic scleroderma	0.000563	0.00235	CcSEcCtD
Midodrine—Asthenia—Captopril—systemic scleroderma	0.000563	0.00235	CcSEcCtD
Midodrine—Dermatitis—Mometasone—systemic scleroderma	0.000562	0.00235	CcSEcCtD
Midodrine—Confusional state—Lisinopril—systemic scleroderma	0.00056	0.00233	CcSEcCtD
Midodrine—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.00056	0.00233	CcSEcCtD
Midodrine—Headache—Mometasone—systemic scleroderma	0.000559	0.00233	CcSEcCtD
Midodrine—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000558	0.00233	CcSEcCtD
Midodrine—Insomnia—Mycophenolic acid—systemic scleroderma	0.000558	0.00233	CcSEcCtD
Midodrine—Pruritus—Captopril—systemic scleroderma	0.000555	0.00231	CcSEcCtD
Midodrine—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000554	0.00231	CcSEcCtD
Midodrine—Pain—Leflunomide—systemic scleroderma	0.000553	0.0023	CcSEcCtD
Midodrine—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.00055	0.00229	CcSEcCtD
Midodrine—Somnolence—Mycophenolic acid—systemic scleroderma	0.000548	0.00229	CcSEcCtD
Midodrine—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000548	0.00228	CcSEcCtD
Midodrine—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000543	0.00226	CcSEcCtD
Midodrine—Tachycardia—Lisinopril—systemic scleroderma	0.000542	0.00226	CcSEcCtD
Midodrine—Abdominal pain—Azathioprine—systemic scleroderma	0.000541	0.00226	CcSEcCtD
Midodrine—Skin disorder—Lisinopril—systemic scleroderma	0.000539	0.00225	CcSEcCtD
Midodrine—Irritability—Methotrexate—systemic scleroderma	0.000535	0.00223	CcSEcCtD
Midodrine—Feeling abnormal—Leflunomide—systemic scleroderma	0.000533	0.00222	CcSEcCtD
Midodrine—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000532	0.00222	CcSEcCtD
Midodrine—Nausea—Mometasone—systemic scleroderma	0.00053	0.00221	CcSEcCtD
Midodrine—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000529	0.0022	CcSEcCtD
Midodrine—Pain—Mycophenolic acid—systemic scleroderma	0.000527	0.0022	CcSEcCtD
Midodrine—Dizziness—Captopril—systemic scleroderma	0.000519	0.00216	CcSEcCtD
Midodrine—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000515	0.00215	CcSEcCtD
Midodrine—Abdominal pain—Leflunomide—systemic scleroderma	0.000511	0.00213	CcSEcCtD
Midodrine—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000508	0.00212	CcSEcCtD
Midodrine—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000506	0.00211	CcSEcCtD
Midodrine—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000504	0.0021	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000504	0.0021	CcSEcCtD
Midodrine—Insomnia—Lisinopril—systemic scleroderma	0.000502	0.00209	CcSEcCtD
Midodrine—Paraesthesia—Lisinopril—systemic scleroderma	0.000499	0.00208	CcSEcCtD
Midodrine—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000496	0.00207	CcSEcCtD
Midodrine—Dyspnoea—Lisinopril—systemic scleroderma	0.000495	0.00206	CcSEcCtD
Midodrine—Rash—Captopril—systemic scleroderma	0.000494	0.00206	CcSEcCtD
Midodrine—Dermatitis—Captopril—systemic scleroderma	0.000494	0.00206	CcSEcCtD
Midodrine—Somnolence—Lisinopril—systemic scleroderma	0.000494	0.00206	CcSEcCtD
Midodrine—Headache—Captopril—systemic scleroderma	0.000491	0.00205	CcSEcCtD
Midodrine—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000491	0.00205	CcSEcCtD
Midodrine—Dyspepsia—Lisinopril—systemic scleroderma	0.000489	0.00204	CcSEcCtD
Midodrine—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000487	0.00203	CcSEcCtD
Midodrine—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000479	0.002	CcSEcCtD
Midodrine—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000477	0.00199	CcSEcCtD
Midodrine—Pain—Lisinopril—systemic scleroderma	0.000475	0.00198	CcSEcCtD
Midodrine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000475	0.00198	CcSEcCtD
Midodrine—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000473	0.00197	CcSEcCtD
Midodrine—Bradycardia—Prednisone—systemic scleroderma	0.000473	0.00197	CcSEcCtD
Midodrine—Nausea—Captopril—systemic scleroderma	0.000466	0.00194	CcSEcCtD
Midodrine—Abdominal discomfort—Methotrexate—systemic scleroderma	0.000465	0.00194	CcSEcCtD
Midodrine—Asthenia—Leflunomide—systemic scleroderma	0.000464	0.00193	CcSEcCtD
Midodrine—Feeling abnormal—Lisinopril—systemic scleroderma	0.000458	0.00191	CcSEcCtD
Midodrine—Pruritus—Leflunomide—systemic scleroderma	0.000457	0.00191	CcSEcCtD
Midodrine—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000454	0.00189	CcSEcCtD
Midodrine—Dysuria—Methotrexate—systemic scleroderma	0.000453	0.00189	CcSEcCtD
Midodrine—Dizziness—Azathioprine—systemic scleroderma	0.000453	0.00189	CcSEcCtD
Midodrine—Asthenia—Mycophenolic acid—systemic scleroderma	0.000442	0.00184	CcSEcCtD
Midodrine—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.00044	0.00184	CcSEcCtD
Midodrine—Abdominal pain—Lisinopril—systemic scleroderma	0.000439	0.00183	CcSEcCtD
Midodrine—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000437	0.00182	CcSEcCtD
Midodrine—Pruritus—Mycophenolic acid—systemic scleroderma	0.000436	0.00182	CcSEcCtD
Midodrine—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000434	0.00181	CcSEcCtD
Midodrine—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000433	0.0018	CcSEcCtD
Midodrine—Rash—Azathioprine—systemic scleroderma	0.000432	0.0018	CcSEcCtD
Midodrine—Dermatitis—Azathioprine—systemic scleroderma	0.000431	0.0018	CcSEcCtD
Midodrine—Flushing—Prednisone—systemic scleroderma	0.000431	0.0018	CcSEcCtD
Midodrine—Headache—Azathioprine—systemic scleroderma	0.000429	0.00179	CcSEcCtD
Midodrine—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000429	0.00179	CcSEcCtD
Midodrine—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000428	0.00179	CcSEcCtD
Midodrine—Dizziness—Leflunomide—systemic scleroderma	0.000427	0.00178	CcSEcCtD
Midodrine—Stomatitis—Methotrexate—systemic scleroderma	0.000421	0.00176	CcSEcCtD
Midodrine—Angiopathy—Prednisone—systemic scleroderma	0.000421	0.00176	CcSEcCtD
Midodrine—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.00042	0.00175	CcSEcCtD
Midodrine—Pain—Mycophenolate mofetil—systemic scleroderma	0.000416	0.00173	CcSEcCtD
Midodrine—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000409	0.0017	CcSEcCtD
Midodrine—Dizziness—Mycophenolic acid—systemic scleroderma	0.000408	0.0017	CcSEcCtD
Midodrine—Rash—Leflunomide—systemic scleroderma	0.000408	0.0017	CcSEcCtD
Midodrine—Dermatitis—Leflunomide—systemic scleroderma	0.000407	0.0017	CcSEcCtD
Midodrine—Mental disorder—Prednisone—systemic scleroderma	0.000407	0.0017	CcSEcCtD
Midodrine—Nausea—Azathioprine—systemic scleroderma	0.000407	0.00169	CcSEcCtD
Midodrine—Headache—Leflunomide—systemic scleroderma	0.000405	0.00169	CcSEcCtD
Midodrine—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000401	0.00167	CcSEcCtD
Midodrine—Asthenia—Lisinopril—systemic scleroderma	0.000398	0.00166	CcSEcCtD
Midodrine—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000398	0.00166	CcSEcCtD
Midodrine—Pruritus—Lisinopril—systemic scleroderma	0.000393	0.00164	CcSEcCtD
Midodrine—Rash—Mycophenolic acid—systemic scleroderma	0.000389	0.00162	CcSEcCtD
Midodrine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000388	0.00162	CcSEcCtD
Midodrine—Headache—Mycophenolic acid—systemic scleroderma	0.000386	0.00161	CcSEcCtD
Midodrine—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000385	0.0016	CcSEcCtD
Midodrine—Nausea—Leflunomide—systemic scleroderma	0.000384	0.0016	CcSEcCtD
Midodrine—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000383	0.0016	CcSEcCtD
Midodrine—Urethral disorder—Methotrexate—systemic scleroderma	0.00038	0.00159	CcSEcCtD
Midodrine—Agitation—Prednisone—systemic scleroderma	0.000371	0.00155	CcSEcCtD
Midodrine—Dizziness—Lisinopril—systemic scleroderma	0.000367	0.00153	CcSEcCtD
Midodrine—Erythema multiforme—Methotrexate—systemic scleroderma	0.000367	0.00153	CcSEcCtD
Midodrine—Nausea—Mycophenolic acid—systemic scleroderma	0.000366	0.00153	CcSEcCtD
Midodrine—Cardiac disorder—Methotrexate—systemic scleroderma	0.00036	0.0015	CcSEcCtD
Midodrine—Angiopathy—Methotrexate—systemic scleroderma	0.000352	0.00147	CcSEcCtD
Midodrine—Rash—Lisinopril—systemic scleroderma	0.00035	0.00146	CcSEcCtD
Midodrine—Dermatitis—Lisinopril—systemic scleroderma	0.00035	0.00146	CcSEcCtD
Midodrine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000349	0.00146	CcSEcCtD
Midodrine—Hypertension—Prednisone—systemic scleroderma	0.000349	0.00145	CcSEcCtD
Midodrine—Chills—Methotrexate—systemic scleroderma	0.000348	0.00145	CcSEcCtD
Midodrine—Headache—Lisinopril—systemic scleroderma	0.000348	0.00145	CcSEcCtD
Midodrine—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000344	0.00144	CcSEcCtD
Midodrine—Anxiety—Prednisone—systemic scleroderma	0.000343	0.00143	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000342	0.00142	CcSEcCtD
Midodrine—Mental disorder—Methotrexate—systemic scleroderma	0.00034	0.00142	CcSEcCtD
Midodrine—Nausea—Lisinopril—systemic scleroderma	0.00033	0.00138	CcSEcCtD
Midodrine—Back pain—Methotrexate—systemic scleroderma	0.000327	0.00136	CcSEcCtD
Midodrine—Nervous system disorder—Prednisone—systemic scleroderma	0.000323	0.00135	CcSEcCtD
Midodrine—Tachycardia—Prednisone—systemic scleroderma	0.000322	0.00134	CcSEcCtD
Midodrine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000322	0.00134	CcSEcCtD
Midodrine—Skin disorder—Prednisone—systemic scleroderma	0.00032	0.00134	CcSEcCtD
Midodrine—Rash—Mycophenolate mofetil—systemic scleroderma	0.000307	0.00128	CcSEcCtD
Midodrine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000307	0.00128	CcSEcCtD
Midodrine—Headache—Mycophenolate mofetil—systemic scleroderma	0.000305	0.00127	CcSEcCtD
Midodrine—Insomnia—Prednisone—systemic scleroderma	0.000298	0.00124	CcSEcCtD
Midodrine—Paraesthesia—Prednisone—systemic scleroderma	0.000296	0.00123	CcSEcCtD
Midodrine—Dyspepsia—Prednisone—systemic scleroderma	0.00029	0.00121	CcSEcCtD
Midodrine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000289	0.00121	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000286	0.00119	CcSEcCtD
Midodrine—Confusional state—Methotrexate—systemic scleroderma	0.000278	0.00116	CcSEcCtD
Midodrine—Feeling abnormal—Prednisone—systemic scleroderma	0.000272	0.00113	CcSEcCtD
Midodrine—Nervous system disorder—Methotrexate—systemic scleroderma	0.00027	0.00113	CcSEcCtD
Midodrine—Gastrointestinal pain—Prednisone—systemic scleroderma	0.00027	0.00112	CcSEcCtD
Midodrine—Skin disorder—Methotrexate—systemic scleroderma	0.000268	0.00112	CcSEcCtD
Midodrine—Abdominal pain—Prednisone—systemic scleroderma	0.000261	0.00109	CcSEcCtD
Midodrine—Insomnia—Methotrexate—systemic scleroderma	0.000249	0.00104	CcSEcCtD
Midodrine—Paraesthesia—Methotrexate—systemic scleroderma	0.000248	0.00103	CcSEcCtD
Midodrine—Dyspnoea—Methotrexate—systemic scleroderma	0.000246	0.00102	CcSEcCtD
Midodrine—Somnolence—Methotrexate—systemic scleroderma	0.000245	0.00102	CcSEcCtD
Midodrine—Dyspepsia—Methotrexate—systemic scleroderma	0.000243	0.00101	CcSEcCtD
Midodrine—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000238	0.000992	CcSEcCtD
Midodrine—Asthenia—Prednisone—systemic scleroderma	0.000237	0.000987	CcSEcCtD
Midodrine—Pain—Methotrexate—systemic scleroderma	0.000236	0.000983	CcSEcCtD
Midodrine—Pruritus—Prednisone—systemic scleroderma	0.000233	0.000973	CcSEcCtD
Midodrine—Feeling abnormal—Methotrexate—systemic scleroderma	0.000227	0.000947	CcSEcCtD
Midodrine—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000225	0.00094	CcSEcCtD
Midodrine—Dizziness—Prednisone—systemic scleroderma	0.000218	0.000909	CcSEcCtD
Midodrine—Abdominal pain—Methotrexate—systemic scleroderma	0.000218	0.000909	CcSEcCtD
Midodrine—Rash—Prednisone—systemic scleroderma	0.000208	0.000867	CcSEcCtD
Midodrine—Dermatitis—Prednisone—systemic scleroderma	0.000208	0.000866	CcSEcCtD
Midodrine—Headache—Prednisone—systemic scleroderma	0.000207	0.000862	CcSEcCtD
Midodrine—Asthenia—Methotrexate—systemic scleroderma	0.000198	0.000825	CcSEcCtD
Midodrine—Nausea—Prednisone—systemic scleroderma	0.000196	0.000817	CcSEcCtD
Midodrine—Pruritus—Methotrexate—systemic scleroderma	0.000195	0.000813	CcSEcCtD
Midodrine—Dizziness—Methotrexate—systemic scleroderma	0.000182	0.00076	CcSEcCtD
Midodrine—Rash—Methotrexate—systemic scleroderma	0.000174	0.000725	CcSEcCtD
Midodrine—Dermatitis—Methotrexate—systemic scleroderma	0.000174	0.000724	CcSEcCtD
Midodrine—Headache—Methotrexate—systemic scleroderma	0.000173	0.00072	CcSEcCtD
Midodrine—Nausea—Methotrexate—systemic scleroderma	0.000164	0.000683	CcSEcCtD
